Below is our recent interview with Zen KOH, Co-Founder and Global CEO at Fourier Intelligence:
Q: Could you provide our readers with a brief introduction to your company?
A: Fourier Intelligence is a medical technology company specialising in rehabilitation robotics that uses artificial intelligence (AI), virtual reality (VR), and big data to develop innovative solutions for individuals with neurological injuries. Our products and services help individuals recover, improve their mobility and function, and are used in hospitals, clinics, and rehabilitation centres worldwide. In addition to our focus on rehabilitation, Fourier Intelligence is committed to advancing the healthcare field through research and collaboration with leading experts in the industry.
Founded by a team of experienced professionals back in 2015 in the fields of robotics, AI, and healthcare, Fourier Intelligence aims to improve the effectiveness and accessibility of rehabilitation services through the use of cutting-edge technology.
My primary motivation for co-founding Fourier Intelligence is to create the world’s leading health technology company for physical and cognitive rehabilitation with healthcare robotics and augmented intelligence systems. We believe in working with others to help us chart a new frontier of innovative medical technologies. We now have over 36 partners in 56 countries to help us provide more than 200 turnkey solutions to our users.
Q: Any highlights on your recent announcement?
A: Fourier Intelligence has recently announced joining Electrosuisse, a global trade association for the electrical, energy, and information technology industries. As a member of Electrosuisse, Fourier Intelligence will have the opportunity to connect with other organisations and individuals in these industries and benefit from the resources and support offered by the trade association. We wish to expand our network further, access new opportunities, and contribute to the development and advancement of these industries. Being a member of Electrosuisse also aligns with our mission and commitment to developing economical and safe medical devices for our clients and partners.
Since our formation, we have established, strengthened and increased partnerships with medical institutions, universities, insurers, and leading professional societies to achieve our mission better.
Another notable highlight is the renewal of another five years, after the initial three successful years of collaboration, of research Memorandum of understanding (MOU) with the Shirley Ryan AbilityLab. The Shirley Ryan AbilityLab, formerly the Rehabilitation Institute of Chicago (RIC), is a not-for-profit nationally-ranked physical medicine and rehabilitation research hospital based in Chicago, Illinois. Founded in 1954, the AbilityLab is designed for patient care, education, and research in physical medicine and rehabilitation (PM&R). The AbilityLab specialises in rehabilitation for adults and children with the most severe, complex conditions ranging from traumatic brain and spinal cord injury to stroke, amputation and cancer-related impairment.
Recommended: An Interview With Bryan Forrester, Co-Founder And CEO At Boostlingo
Q: Can you give us more insights into your offering?
A: Fourier Intelligence is now considered one of the leading rehabilitation technology brands. We routinely reinvest revenue from our products in research and development to advance our offerings and improve lives everywhere. Our goal is to create an ecosystem that supports everyone, empowers people with disabilities, patients with neurological conditions, or seniors and provides clinicians and caregivers with life-changing tools.
Our RehabHub™ has since become a standard service. It has been widely installed and is helping thousands of patients with complex needs in their daily lives. We succeeded by making the tools available and affordable so people can use them to improve their lives.
Group Therapy Concept, along with our RehabHub™, allow the use of software and technology combined with AI to perform repetitive tasks quickly, efficiently, and accurately with data extraction from movements generated during the rehabilitation process. This help to release existing clinical staff to perform more productive tasks, such as challenging the patients and personalising the treatment protocols. It enables integrated advanced rehabilitation robotics that mimics manual clinical interventions with minimum changes in the existing clinical pathway.
Fourier Intelligence’s open platform system EXOPS™ (Exoskeleton & Robotics Open Platform System) enables all suppliers to plug directly into the Fourier ecosystem to provide solutions with better results. This approach provides customers with more choices, better solutions and lower costs and is geared towards empowering clinicians and patients during their rehabilitation journey using robotics and AI.
Another highlight is the launch of the ArmMotus™ EMU through technology transfer arrangements with the Fourier-UoM (University of Melbourne) Joint Laboratory. The ArmMotus™ EMU is a 3D back-drivable upper limb rehabilitation robot that adopted an innovative cable-driven mechanism combined with a parallel structure of lightweight carbon fibre rods that reduces the device’s friction and inertia for higher compliance in human-machine interaction. It has since won four global accolades: the Red Dot Design Award, the iF Design Award, the Medical Design Excellence Award, and the Good Design Award.
Q: What can we expect from your company in the next 6 months? What are your plans?
A: Despite the challenging global pandemic, Fourier intelligence has successfully raised investment rounds from SoftBank Vision Fund 2, Saudi Aramco P7 Venture Fund and the Yuanjing Vision Plus Capital. These investments signify endorsement and recognition of our work. The experience and capital that our strategic investors bring to Fourier Intelligence will help us rapidly realise global commercialisation and deliver innovative therapies to as many patients as possible.
In the next six months, Fourier Intelligence will launch new products (please stay tuned!) that are even more user-friendly and effective at improving patient outcomes for the next six months. We will continue to expand our market presence in key markets through targeted marketing campaigns and partnerships with rehabilitation centres and hospitals. We will invest in research and development to improve our products and stay at the forefront of the industry. We will increase our profitability by streamlining operations and identifying new revenue streams.
Recommended: Meet BAU – A Platform That Helps Local Businesses And Its Customers Form Long Lasting Connections With Each Other
Q: What is the best thing about your company that people might not know about?
A: I think many did not realise that we are trying to create a new rehabilitation technology world where everyone can access the tools and resources they need to achieve their dreams in supporting the advancement of the rehabilitation profession. Some still think that we are just a company making rehabilitation technology products.
Fourier Intelligence owes its success to the hard work of our passionate team. There is no secret recipe here – just hard work and a common cause. The best thing others do not know about is our team of passionate individuals, institutions, and thinkers coming together in an open ecosystem to collaborate, productively and efficiently, toward their mutual benefit and harness technology’s power to change patients’ lives for the better. This is the culture we try to create, and this is the best thing we got and keeps us going. We want to build a change-maker and are committed to creating a better future of inclusive, sustainable development through healthcare technology. We will continue to do so in Fourier Intelligence and keep pushing the frontier of technology.